BioNTech SE (BNTX) Change in Inventory (2018 - 2025)
BioNTech SE (BNTX) posted Change in Inventory of $135.3 million for Q4 2025, up 2168.66% on a QoQ basis from $6.0 million in Q3 2025, and up 536.08% year-over-year from $21.3 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Change in Inventory data on file, last reported at $135.3 million in Q4 2025.
- In Q4 2025, Change in Inventory rose 536.08% year-over-year to $135.3 million; the TTM figure through Dec 2025 stood at $202.6 million (up 150.2% YoY), while the FY2025 annual figure was $201.0 million, up 152.47% from the prior year.
- Change in Inventory advanced to $135.3 million in Q4 2025, from $6.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $135.3 million in Q4 2025 and bottomed at -$388.3 million in Q3 2021.
- A 5-year average of -$13.0 million and a median of $19.0 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory sank 212329714.98% — and 2022, when it surged 48545115.36%.
- Year by year, Change in Inventory stood at -$124.8 million in 2021, then fell by 18.37% to -$147.7 million in 2022, then surged by 142.24% to $62.4 million in 2023, then tumbled by 65.92% to $21.3 million in 2024, then surged by 536.08% to $135.3 million in 2025.
- The last three Change in Inventory figures came in at $135.3 million (Q4 2025), $6.0 million (Q3 2025), and $25.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 135.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 135.26 Mn |
| Dec 31, 2025 | 135.26 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Sep 30, 2023 | 36.14 Mn |
| Sep 30, 2023 | 36.14 Mn |
| Jun 30, 2023 | -27.01 Mn |
| Jun 30, 2023 | -27.01 Mn |
| Mar 31, 2023 | 16.64 Mn |
| Mar 31, 2023 | 16.64 Mn |
| Dec 31, 2022 | -147.73 Mn |
| Dec 31, 2022 | -147.73 Mn |
| Sep 30, 2022 | 73.50 Mn |
| Sep 30, 2022 | 73.50 Mn |
| Jun 30, 2022 | 97.74 Mn |
| Jun 30, 2022 | 97.74 Mn |
| Mar 31, 2022 | 48.48 Mn |
| Mar 31, 2022 | 48.48 Mn |
| Dec 31, 2021 | -124.81 Mn |
| Dec 31, 2021 | -124.81 Mn |
| Sep 30, 2021 | -388.34 Mn |
| Sep 30, 2021 | -388.34 Mn |
| Jun 30, 2021 | -190.88 Mn |
| Jun 30, 2021 | -190.88 Mn |
| Mar 31, 2021 | -99.88 |
| Mar 31, 2021 | -99.88 |
| Dec 31, 2020 | -58.78 |
| Dec 31, 2020 | -58.78 |
| Mar 31, 2020 | 2.43 Mn |
| Mar 31, 2020 | 2.43 Mn |
| Dec 31, 2019 | -946,388.96 |
| Dec 31, 2019 | -946,388.96 |
| Dec 31, 2018 | 1.74 Mn |
| Dec 31, 2018 | 1.74 Mn |